Heil, K.M.; Helmschrott, M.; Darche, F.F.; Bruckner, T.; Ehlermann, P.; Kreusser, M.M.; Doesch, A.O.; Sommer, W.; Warnecke, G.; Frey, N.;
et al. Risk Factors, Treatment and Prognosis of Patients with Lung Cancer after Heart Transplantation. Life 2021, 11, 1344.
https://doi.org/10.3390/life11121344
AMA Style
Heil KM, Helmschrott M, Darche FF, Bruckner T, Ehlermann P, Kreusser MM, Doesch AO, Sommer W, Warnecke G, Frey N,
et al. Risk Factors, Treatment and Prognosis of Patients with Lung Cancer after Heart Transplantation. Life. 2021; 11(12):1344.
https://doi.org/10.3390/life11121344
Chicago/Turabian Style
Heil, Karsten M., Matthias Helmschrott, Fabrice F. Darche, Tom Bruckner, Philipp Ehlermann, Michael M. Kreusser, Andreas O. Doesch, Wiebke Sommer, Gregor Warnecke, Norbert Frey,
and et al. 2021. "Risk Factors, Treatment and Prognosis of Patients with Lung Cancer after Heart Transplantation" Life 11, no. 12: 1344.
https://doi.org/10.3390/life11121344
APA Style
Heil, K. M., Helmschrott, M., Darche, F. F., Bruckner, T., Ehlermann, P., Kreusser, M. M., Doesch, A. O., Sommer, W., Warnecke, G., Frey, N., & Rivinius, R.
(2021). Risk Factors, Treatment and Prognosis of Patients with Lung Cancer after Heart Transplantation. Life, 11(12), 1344.
https://doi.org/10.3390/life11121344
